Ventricular septal defect post-surgical prognosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ventricular septal defect}} | {{Ventricular septal defect}} | ||
{{CMG}}and Leida Perez, M.D.; '''Associate Editor-In-Chief:''' [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu], [[Priyamvada Singh]], [[MBBS]] | {{CMG}}and Leida Perez, M.D.; '''Associate Editor-In-Chief:''' [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu], [[Priyamvada Singh]], [[MBBS]] | ||
== | == Post-operative Treatment == | ||
==Post-operative | ===Post-operative course=== | ||
* The operative mortality for an elective repair is less than 2%. | |||
* | * It is increased by the presence of associated anomalies, multiple defects, or if there is severe [[pulmonary hypertension]]. | ||
* | * Late follow-up shows that their life expectancy is restored to that of age matched controls (except in those over the age of three with severe pulmonary hypertension). | ||
* | * There is a residual defect in 14% to 25% of patients which is hemodynamically insignificant | ||
* | * A persistent [[RBBB]] in the majority of patients due to disruption of the [[Purkinje fibers]]. | ||
* | * In patients over 3 at the time of the operation, there is often residual and progressive pulmonary hypertension and or residual [[ventricular dysfunction]]. | ||
* | * The risk of [[endocarditis]] following closure is similar to that in the general population. Because small defects are frequent, [[antibiotic]] prophylaxis is still recommended. | ||
== References == | |||
==References== | |||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Cardiology]] | |||
[[Category:Congenital heart disease]] | |||
[[Category:Pediatrics]] | |||
[[Category:Disease]] | |||
[[Category:Needs overview]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 18:23, 8 January 2013
|
Ventricular septal defect Microchapters | |
|
Differentiating Ventricular Septal Defect from other Diseases | |
|---|---|
|
Diagnosis | |
|
ACC/AHA Guidelines for Surgical and Catheter Intervention Follow-Up | |
|
Case Studies | |
|
Ventricular septal defect post-surgical prognosis On the Web | |
|
American Roentgen Ray Society Images of Ventricular septal defect post-surgical prognosis | |
|
Ventricular septal defect post-surgical prognosis in the news | |
|
Risk calculators and risk factors for Ventricular septal defect post-surgical prognosis | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]and Leida Perez, M.D.; Associate Editor-In-Chief: Keri Shafer, M.D. [2], Priyamvada Singh, MBBS
Post-operative Treatment
Post-operative course
- The operative mortality for an elective repair is less than 2%.
- It is increased by the presence of associated anomalies, multiple defects, or if there is severe pulmonary hypertension.
- Late follow-up shows that their life expectancy is restored to that of age matched controls (except in those over the age of three with severe pulmonary hypertension).
- There is a residual defect in 14% to 25% of patients which is hemodynamically insignificant
- A persistent RBBB in the majority of patients due to disruption of the Purkinje fibers.
- In patients over 3 at the time of the operation, there is often residual and progressive pulmonary hypertension and or residual ventricular dysfunction.
- The risk of endocarditis following closure is similar to that in the general population. Because small defects are frequent, antibiotic prophylaxis is still recommended.